Maternal metabolic control and perinatal outcome in women with gestational diabetes mellitus treated with lispro or aspart insulin: comparison with regular insulin

Diabetes Care. 2007 Apr;30(4):e11. doi: 10.2337/dc06-2586.
No abstract available

Publication types

  • Letter
  • Randomized Controlled Trial

MeSH terms

  • Blood Glucose / analysis
  • Cohort Studies
  • Diabetes, Gestational / blood
  • Diabetes, Gestational / drug therapy*
  • Female
  • Glycated Hemoglobin / analysis
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Infant, Newborn
  • Insulin / analogs & derivatives*
  • Insulin / therapeutic use
  • Insulin Aspart
  • Insulin Lispro
  • Insulin, Isophane / therapeutic use*
  • Perinatal Care
  • Pregnancy
  • Weight Gain

Substances

  • Blood Glucose
  • Glycated Hemoglobin A
  • Hypoglycemic Agents
  • Insulin
  • Insulin Lispro
  • Insulin, Isophane
  • Insulin Aspart